We care

about the people we serve

We battle

to make progress

in a conservative world

We think

about how our innovations

can impact many lives

We live

to make a difference

We Serve Society

with Science Based Solutions


Our story

Genes are responsible for making us who we are. It can determine our features such hair and eye color, skin tone, or even height. Although we know our genetic make-up is similar to one another, each individual is vastly unique. “No two humans are alike.”

 

And while most agree on the quote above, the contrary is being practiced in disease treatment today. When a patient gets a cancer diagnosis, he or she is treated, more or less, the same as other patients with the same type of cancer. For decades we have known, but were not able to determine why patients with the same diagnosis respond differently to the same treatment. Today, after years of genetic research, we know that like humans, no two cancer cells are alike. And for that reason, we now know cancer treatments should differ case by case, because cancer cells are inherently different.

 

At SkylineDx, we have a team of experts with the knowledge and capability to collaborate with highly respected physicians and patients advocates. Together we work to achieve the same multi-disciplinary goal: to give physicians the genetic tools to better guide the most affective treatment plan for their patients.

 

This principle of individualized treatment plans is called personalized- or precision medicine and is extremely important for the patient. With the right personalized treatment, at the right moment, the patient can avoid side effects from over or undertreatment, which means less hospitalization, complications, medications, and ultimately better quality of life.


Our diagnostics

We are determined to empower innovative and personalized treatment of various disease and are building a comprehensive range of world class diagnostic solutions on the cutting edge of technology and genetics. Discover the superior power of our data-driven gene signature-based diagnostic tests and machine learning algorithms.

read more

Latest news

The Dutch government grants €2.7M for the development of a skin cancer test. “It is great recognition that the Dutch government, as an independent party, expresses its confidence in our capacity to successfully develop this test and bring value to the doctor and their patients globally,” says Dharminder Chahal, CEO SkylineDx. 

read more

Meet our team

Don't be surprised if you walk in our hallways and find people dancing (often in combination with singing) behind standing desks or throwing around rugby balls. Whatever works to get the adrenaline going for the next round of meetings and battles against anything standing between our diagnostic tests and the hands of a physician.

read more